These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 8626362)

  • 61. The efficacy, tolerability, and safety of contemporary antidepressants.
    Papakostas GI
    J Clin Psychiatry; 2010; 71 Suppl E1():e03. PubMed ID: 20371030
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Controlled comparison of nefazodone and amitriptyline in major depressive inpatients.
    Ansseau M; Darimont P; Lecoq A; De Nayer A; Evrard JL; Krémer P; Devoitille JM; Dierick M; Mertens C; Mesotten F
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):254-60. PubMed ID: 7862904
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nefazodone in the treatment of premenstrual syndrome: a preliminary study.
    Freeman EW; Rickels K; Sondheimer SJ; Denis A; Pfeifer S; Weil S
    J Clin Psychopharmacol; 1994 Jun; 14(3):180-6. PubMed ID: 8027414
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
    Ferguson JM; Shrivastava RK; Stahl SM; Hartford JT; Borian F; Ieni J; McQuade RD; Jody D
    J Clin Psychiatry; 2001 Jan; 62(1):24-9. PubMed ID: 11235924
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
    Preskorn SH
    J Clin Psychiatry; 1995; 56 Suppl 6():12-21. PubMed ID: 7649968
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antidepressant drug studies in the elderly.
    Rockwell E; Lam RW; Zisook S
    Psychiatr Clin North Am; 1988 Mar; 11(1):215-33. PubMed ID: 2898134
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Safety and tolerability of dexmecamylamine (TC-5214) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to antidepressant therapy: results of a long-term study.
    Tummala R; Desai D; Szamosi J; Wilson E; Hosford D; Dunbar G; Eriksson H
    J Clin Psychopharmacol; 2015 Feb; 35(1):77-81. PubMed ID: 25514064
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nefazodone: preclinical pharmacology of a new antidepressant.
    Eison AS; Eison MS; Torrente JR; Wright RN; Yocca FD
    Psychopharmacol Bull; 1990; 26(3):311-5. PubMed ID: 2274630
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Review of bupropion.
    Bryant SG; Guernsey BG; Ingrim NB
    Clin Pharm; 1983; 2(6):525-37. PubMed ID: 6140095
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The safety and tolerability of citalopram.
    Muldoon C
    Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():35-40. PubMed ID: 8732443
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fluoxetine: a five-year review.
    Stokes PE
    Clin Ther; 1993; 15(2):216-43; discussion 215. PubMed ID: 8519034
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The antidepressant nefazodone. A review of its pharmacology, clinical efficacy, adverse effects, dosage, and administration.
    Khouzam HR
    J Psychosoc Nurs Ment Health Serv; 2000 Aug; 38(8):20-5. PubMed ID: 10959472
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy and tolerability of milnacipran: an overview.
    Montgomery SA; Prost JF; Solles A; Briley M
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():47-51. PubMed ID: 8923127
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nomifensine maleate: a new second-generation antidepressant.
    Kinney JL
    Clin Pharm; 1985; 4(6):625-36. PubMed ID: 3907935
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nefazodone pharmacokinetics in depressed children and adolescents.
    Findling RL; Preskorn SH; Marcus RN; Magnus RD; D'Amico F; Marathe P; Reed MD
    J Am Acad Child Adolesc Psychiatry; 2000 Aug; 39(8):1008-16. PubMed ID: 10939229
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expanding psychopharmacologic treatment options for the depressed medical patient.
    Stoudemire A
    Psychosomatics; 1995; 36(2):S19-26. PubMed ID: 7724709
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reboxetine, the first selective noradrenaline reuptake inhibitor antidepressant: Efficacy and tolerability in 2613 patients.
    Versiani M
    Int J Psychiatry Clin Pract; 2000; 4(3):201-8. PubMed ID: 24927454
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Cardiac effects of atropine in patients treated with antidepressive medication].
    Hansen D; Syben R; Föhring U; Eyrich K
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1994 Nov; 29(7):413-6. PubMed ID: 7819467
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacology of antidepressants: focus on nefazodone.
    DeVane CL; Grothe DR; Smith SL
    J Clin Psychiatry; 2002; 63 Suppl 1():10-7. PubMed ID: 11890560
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future.
    Taylor WD; Doraiswamy PM
    Neuropsychopharmacology; 2004 Dec; 29(12):2285-99. PubMed ID: 15340391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.